Expression of MALAT1 in the peripheral whole blood of patients with lung cancer

Biomedical Reports

Volumn 3, Issue 3, 2015, Pages 309-312

  Guo, Fengjie ^a   Yu, Fang ^b   Wang, Jing ^a   Li, Yongwen ^a   Li, Ying ^a   Li, Zhigang ^a   Zhou, Qinghua ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b HEBEI GENERAL HOSPITAL   (China)

Author keywords

Lung cancer; MALAT1; Quantitative polymerase chain reaction

Indexed keywords

COMPLEMENTARY DNA; LONG UNTRANSLATED RNA; PROTEIN MALAT1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BONE METASTASIS; BRAIN METASTASIS; CARCINOMA IN SITU; CONTROLLED STUDY; DNA SYNTHESIS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LUNG CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PLEURA METASTASIS; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RNA ISOLATION; SENSITIVITY AND SPECIFICITY; SERIAL ANALYSIS OF GENE EXPRESSION;

EID: 84969259508     PISSN: 20499434     EISSN: 20499442     Source Type: Journal    
DOI: 10.3892/br.2015.422     Document Type: Article

References (20)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J and Thun MJ: Cancer statistics, 2009. CA Cancer J Clin 59: 225‑249, 2009.
2. Patnaik SK, Yendamuri S, Kannisto E, Kucharczuk JC, Singhal S and Vachani A: MicroRNA expression profiles of whole blood in lung adenocarcinoma. PLoS One 7: e46045, 2012.
3. Zaatar AM, Lim CR, Bong CW, et al: Whole blood transcriptome correlates with treatment response in nasopharyngeal carcinoma. J Exp Clin Cancer Res 31: 76, 2012.
4. Isaksson HS, Sorbe B and Nilsson TK: Whole blood RNA expression profiles in ovarian cancer patients with or without residual tumors after primary cytoreductive surgery. Oncol Rep 27: 1331‑1335, 2012.
5. Du YZ, Gu XH, Li L and Gao F: The diagnostic value of circulating stanniocalcin‑1 mRNA in non‑small cell lung cancer. J Surg Oncol 104: 836‑840, 2011.
6. Rotunno M, Hu N, Su H, et al: A gene expression signature from peripheral whole blood for stage I lung adenocarcinoma. Cancer Prev Res (Phila) 4: 1599‑1608, 2011.
7. Ji P, Diederichs S, Wang W, et al: MALAT‑1, a novel noncoding RNA and thymosin beta4 predict metastasis and survival in early‑stage non‑small cell lung cancer. Oncogene 22: 8031‑8041, 2003.
8. Lin R, Maeda S, Liu C, Karin M and Edgington TS: A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas. Oncogene 26: 851‑858, 2007.
9. Tripathi V, Shen Z, Chakraborty A, et al: Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor B‑MYB. PLoS Genet 9: e1003368, 2013.
10. Szymanski M, Barciszewska MZ, Erdmann VA and Barciszewski J: A new frontier for molecular medicine: Noncoding RNAs. Biochim Biophys Acta 1756: 65‑75, 2005.
11. Hutchinson JN, Ensminger AW, Clemson CM, Lynch CR, Lawrence JB and Chess A: A screen for nuclear transcripts iden-tifies two linked noncoding RNAs associated with SC35 splicing domains. BMC Genomics 8: 39, 2007.
12. Guo F, Li Y, Liu Y, Wang J, Li Y and Li G: Inhibition of metastasis‑associated lung adenocarcinoma transcript 1 in CaSki human cervical cancer cells suppresses cell proliferation and invasion. Acta Biochim Biophys Sin (Shanghai) 42: 224‑229, 2010.
13. Tano K, Mizuno R, Okada T, Rakwal R, Shibato J, Masuo Y, Ijiri K and Akimitsu N: MALAT‑1 enhances cell motility of lung adenocarcinoma cells by influencing the expression of motility‑related genes. FEBS Lett 584: 4575‑4580, 2010.
14. Lai MC, Yang Z, Zhou L, Zhu QQ, Xie HY, Zhang F, Wu LM, Chen LM and Zheng SS: Long non‑coding RNA MALAT‑1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med Oncol 29: 1810‑1816, 2012.
15. Xie H, Ma H and Zhou D: Plasma HULC as a promising novel biomarker for the detection of hepatocellular carcinoma. Biomed Res Int 2013: 136106, 2013.
16. Arita T, Ichikawa D, Konishi H, et al: Circulating long non‑coding RNAs in plasma of patients with gastric cancer. Anticancer Res 33: 3185‑3193, 2013.
17. Sun Y, Wang Z and Zhou D: Long non‑coding RNAs as potential biomarkers and therapeutic targets for gliomas. Med Hypotheses 81: 319‑321, 2013.
18. Passtoors WM, Beekman M, Deelen J, et al: Gene expression analysis of mTOR pathway: Association with human longevity. Aging Cell 12: 24‑31, 2013.
19. Olmos D, Brewer D, Clark J, et al: Prognostic value of blood mRNA expression signatures in castration‑resistant prostate cancer: A prospective, two‑stage study. Lancet Oncol 13: 1114‑1124, 2012.
20. Ross RW, Galsky MD, Scher HI, et al: A whole‑blood RNA tran-script‑based prognostic model in men with castration‑resistant prostate cancer: A prospective study. Lancet Oncol 13: 1105‑1113, 2012.